A phase II clinical trial of chidamide in combination with toripalimab in patients with advanced soft tissue sarcoma

被引:0
|
作者
Zhang, Xing
Peng, Ruiqing
Pan, Qiuzhong
Xu, Bushu
Hong, Dongchun
Que, Yi
机构
[1] Sun Yat Sen Univ, Dept Med Melanoma & Sarcoma, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Melanoma & Sarcoma Med Oncol Unit, Ctr Canc, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Med Melanoma & Sarcoma, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
11566
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma
    Cho, Hee Jin
    Sim, Nam Suk
    Shin, Su-Jin
    Yun, Kum-Hee
    Lee, Young Han
    Jun, Hyun Jung
    Rha, Sun Young
    Kim, Hyo Song
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] PHASE-II TRIAL OF TRIMETREXATE IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA
    LICHT, JD
    GONIN, R
    ANTMAN, KH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (03) : 223 - 225
  • [3] Phase II Trial of Cetuximab in Patients With Metastatic or Locally Advanced Soft Tissue or Bone Sarcoma
    Ha, Huan T.
    Griffith, Kent A.
    Zalupski, Mark M.
    Schuetze, Scott M.
    Thomas, Dafydd G.
    Lucas, David R.
    Baker, Laurence H.
    Chugh, Rashmi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (01): : 77 - 82
  • [4] A PHASE-II TRIAL OF PALA + DIPYRIDAMOLE IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA
    CASPER, ES
    BASELGA, J
    SMART, TB
    MAGILL, GB
    MARKMAN, M
    RANHOSKY, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (01) : 51 - 54
  • [5] A phase II trial of novel anthracycline amrubicin in advanced soft tissue sarcoma
    Gouw, Launce
    Randall, R. Lor
    Jones, Kevin
    Chawla, Sant P.
    Sharma, Sunil
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Phase II trial of paclitaxel in patients with soft-tissue sarcoma
    Casper, ES
    Waltzman, RJ
    Schwartz, GK
    Sugarman, A
    Pfister, D
    Ilson, D
    Woodruff, J
    Leung, D
    Bertino, JR
    CANCER INVESTIGATION, 1998, 16 (07) : 442 - 446
  • [7] Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
    Hee Jin Cho
    Kum-Hee Yun
    Su-Jin Shin
    Young Han Lee
    Seung Hyun Kim
    Wooyeol Baek
    Yoon Dae Han
    Sang Kyum Kim
    Hyang Joo Ryu
    Joohee Lee
    Iksung Cho
    Heounjeong Go
    Jiwon Ko
    Inkyung Jung
    Min Kyung Jeon
    Sun Young Rha
    Hyo Song Kim
    Nature Communications, 15
  • [8] Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
    Cho, Hee Jin
    Yun, Kum-Hee
    Shin, Su-Jin
    Lee, Young Han
    Kim, Seung Hyun
    Baek, Wooyeol
    Han, Yoon Dae
    Kim, Sang Kyum
    Ryu, Hyang Joo
    Lee, Joohee
    Cho, Iksung
    Go, Heounjeong
    Ko, Jiwon
    Jung, Inkyung
    Jeon, Min Kyung
    Rha, Sun Young
    Kim, Hyo Song
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [9] A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma
    Christopher W. Ryan
    M. Eileen Dolan
    Bruce B. Brockstein
    Roger McLendon
    Shannon M. Delaney
    Brian L. Samuels
    Edem S. Agamah
    Everett E. Vokes
    Cancer Chemotherapy and Pharmacology, 2006, 58
  • [10] A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma
    Ryan, Christopher W.
    Dolan, M. Eileen
    Brockstein, Bruce B.
    McLendon, Roger
    Delaney, Shannon M.
    Samuels, Brian L.
    Agamah, Edem S.
    Vokes, Everett E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (05) : 634 - 639